Condiciones de salud que plátano puede ayudar a apoyar.
P. major extracts contain multiple potent antioxidant compounds including plantamajoside, acteoside, caffeic acid, luteolin, and apigenin. Multiple in vitro and in vivo studies confirm robust free radical scavenging activity (DPPH assay), protection against oxidative stress in liver mitochondria and cell lines, and reduction of reactive oxygen species in biological systems.
Psyllium (P. ovata) supplementation demonstrated significant blood pressure reduction in diabetic patients in a randomized clinical trial. A systematic review of Plantago RCTs found that among its documented health benefits, blood pressure lowering (secondary to weight loss) is one of five major FDA-recognized benefits. P. lanceolata has traditional use for hypertension.
Plantago major extracts show hypoglycemic activity in multiple animal models, attributed to flavonoid compounds and insulin-stimulating effects. Plantago psyllium (P. ovata) has human clinical evidence for blood glucose lowering in type 2 diabetes as adjunct therapy, with a double-blind placebo-controlled RCT in 125 subjects. P. major has been used as a folk remedy for diabetes in Europe and Asia.
Plantain herb has preclinical and clinical evidence relevant to bronchial health, including an RCT demonstrating reduction of bronchitis symptoms, sputum production, and bronchial irritation. In vitro studies confirm that P. lanceolata extract reduces bradykinin-mediated inflammatory responses in bronchial epithelial cells and modulates NF-κB signaling.
A double-blind randomized controlled trial tested Plantago major syrup (30 ml/day for 10 days) in 80 patients with acute bronchitis. The P. major group showed significantly lower Bronchitis Severity Scale scores, cough frequency, sputum volume, and chest wall pain compared to placebo. This represents direct clinical evidence for P. major in bronchitis.
A case-control clinical study directly evaluated P. major 10% ointment versus silver sulfadiazine 1% in second-degree burn wound patients. The plant's antimicrobial and anti-inflammatory compounds are proposed as the active drivers of burn wound improvement. Traditional use of fresh leaves on burns is also well-documented globally.
A 2024 systematic review and meta-analysis of 29 RCTs (n=2769) found Plantago consumption significantly reduced total cholesterol by 0.28 mmol/L and LDL-C by 0.35 mmol/L versus control. Effects were attributable primarily to psyllium/Plantago husk and soluble fiber. A single RCT (n=125, double-blind, placebo-controlled) also confirmed cholesterol lowering with psyllium in type 2 diabetes patients.
Multiple in vitro and in vivo studies have characterized anti-inflammatory mechanisms in Plantago major. Key compounds—aucubin, plantamajoside, ursolic acid, and oleanolic acid—inhibit COX enzymes, histamine release, elastase, and complement activity. These mechanisms are supported at the cellular level, though dedicated human RCTs for chronic inflammatory conditions remain limited.
A randomized clinical trial found Plantago ovata seeds equivalent to mesalamine for UC remission maintenance. Psyllium fiber specifically protected against experimental colitis in mouse models where other fibers worsened disease. A case report documented improvement in refractory ulcerative pancolitis with P. major. The protective mechanism involves SCFA production and intestinal barrier maintenance.
Plantago ovata (psyllium) husk is the gold-standard dietary fiber for regulating bowel movements, with robust clinical evidence from numerous RCTs for both constipation and diarrhea. The gel-forming arabinoxylan retains water in a mucous-gel structure, softening and bulking stools. Psyllium is recommended by the American College of Gastroenterology for IBS, which frequently presents with constipation.
Plantago psyllium (P. ovata) husk has documented clinical efficacy for both acute and chronic diarrhea, including diarrhea caused by enteral feeding. As a bulking agent, the gel-forming fiber absorbs excess luminal fluid and slows transit. P. major leaves with tannin content also show traditional antidiarrheal use with astringent preclinical support.
Plantago polysaccharides (particularly psyllium arabinoxylan) regulate gut microbiota composition in clinical studies. Psyllium increases SCFA-producing bacteria (Faecalibacterium, Lachnospira, Phascolarctobacterium) and modulates Bifidobacterium in a baseline-dependent manner in human studies. These microbiome changes support colonic health, immune modulation, and intestinal barrier integrity.
Psyllium (Plantago ovata husk) has documented clinical benefits for hemorrhoids, listed alongside constipation, IBS, and diarrhea in a 2024 PMC systematic review of clinical evidence. By softening stools and reducing straining, psyllium fiber directly reduces hemorrhoidal irritation and recurrence. Traditional use of P. major for hemorrhoids is also documented.
Psyllium (Plantago ovata husk) is the only fiber recommended by the American College of Gastroenterology for irritable bowel syndrome. It is the sole fiber meeting evidence criteria for IBS management. Multiple clinical trials support its use for IBS-related constipation, diarrhea, and abdominal discomfort via its gel-forming, microbiota-modulating fiber action.
Plantago ovata seeds were compared head-to-head against mesalamine in a randomized clinical trial for maintaining remission in ulcerative colitis. P. major was reported helpful in a case of refractory ulcerative pancolitis. Psyllium fiber is protective against experimental colitis and modulates gut microbiota and intestinal barrier—both central IBD mechanisms.
Psyllium (Plantago ovata) supplementation has been shown preclinically to restore tight junction protein expression, improve intestinal barrier integrity, and reduce intestinal permeability. These effects were demonstrated in colitis mouse models and CKD rat models. Improved gut barrier function is a key mechanism behind psyllium's broader GI benefits.
Plantago contains mucilage polysaccharides and expectorant constituents that act on mucous membranes to reduce excessive mucus production and facilitate expectoration. Clinical improvements in sputum production were observed in the P. major acute bronchitis RCT. Plantago lanceolata is recognized as an expectorant in official monographs.
In vitro evidence demonstrates that Plantago lanceolata extract reduces NF-κB-driven inflammation in tonsil epithelial cells, with measurable reduction in inflammatory mediators. Traditional use for mouth and throat inflammation is recorded in Ayurvedic, Traditional Chinese, and European herbal systems. A registered EU herbal medicine (StrepCough) uses P. lanceolata for sore throat.
A randomized clinical trial of P. major seed in NAFLD patients found significant reductions in triglycerides (P=0.001) after 12 weeks of supplementation at 2 g/day. Psyllium soluble fiber specifically lowered triglycerides in a subgroup analysis of a 2024 meta-analysis. A double-blind placebo-controlled RCT (n=125) with psyllium in type 2 diabetes also found significant triglyceride reduction.
Pectic polysaccharides from P. major have demonstrated antiulcerogenic effects in rat models. A randomized controlled clinical trial found P. major hydroalcoholic extract gel accelerated healing of diabetic foot ulcers and pressure ulcers in humans. P. major syrup reduced radiation-induced oral mucositis in an RCT. Traditional antiulcer use spans multiple global traditions.
Plantago lanceolata is officially used and pharmacopoeially recognized for upper respiratory tract infections including cough and pharyngeal inflammation. P. major extracts show anti-inflammatory, spasmolytic, and antimicrobial activity in the upper airways. Human trials and monograph-level recognition support this application.
P. major aqueous extract has been tested in vitro against herpesviruses (HSV-1, HSV-2) and adenoviruses (ADV-3, ADV-8, ADV-11), showing slight anti-herpes activity. Immunostimulatory activity has been confirmed experimentally. Pectic polysaccharides from P. major have immunostimulatory properties. P. major is a long-standing traditional Chinese medicine for viral diseases from cold to viral hepatitis.
Plantago major has clinical and extensive preclinical evidence for wound healing. A case-control study compared P. major 10% ointment against silver sulfadiazine in second-degree burn patients. A randomized controlled trial found 10% topical P. major gel accelerated healing of diabetic foot ulcers and pressure ulcers. Mechanisms include antioxidant, anti-inflammatory, and antimicrobial effects from polyphenolic compounds, and stimulation of fibroblast proliferation.
Plantain is widely documented in traditional medicine for abdominal pain, intestinal complaints, and stomach discomfort. Its mucilage acts as a soothing demulcent throughout the GI tract. Spasmolytic activity demonstrated in experimental research may reduce abdominal cramping. Plantago is used in treating abdominal pain across multiple ethnobotanical traditions.
Plantain (Plantago spp.) has been used in traditional herbalism for abscesses as a topical poultice, referenced in multiple herbalist texts for drawing and healing abscessed tissue. Scientific studies confirm anti-inflammatory and wound-healing properties in vitro and in animal models. No abscess-specific RCTs exist.
Plantago lanceolata leaves have been traditionally used for arthritis and joint inflammation. Anti-inflammatory mechanisms (COX-1/COX-2 inhibition, NF-κB suppression, histamine inhibition) provide relevant pharmacological rationale. Traditional use for rheumatism and arthritis is documented globally. No dedicated human RCT for arthritis with Plantago has been published.
Plantain is listed in traditional medicine globally for asthma treatment. Preclinical studies in asthmatic rats with P. major extract show reduced lung pathology. P. lanceolata shows antispasmodic activity relevant to bronchoconstriction. No human RCT for asthma specifically has been published.
Plantain (Plantago major/lanceolata) is one of the most consistently cited traditional remedies for insect bites and stings across cultures, used as a fresh-leaf poultice to draw out venom, reduce swelling, and relieve itching. It contains aucubin and allantoin, compounds with documented anti-inflammatory and tissue-soothing actions. Multiple herbal medicine authorities list plantain as a first-choice herb for bites and stings.
Bladder problems are among the classically recorded traditional uses of Plantago major in European, Asian, and Persian folk medicine. Traditional use includes cystitis and bladder inflammation. In vitro antimicrobial activity against uropathogens and documented diuretic effects in preclinical studies support the plausibility of this traditional application.
Plantago major is a traditional Chinese and European folk medicine for colds and flu-like symptoms. It is listed among classic applications for cold, cough, fever, and hoarseness in traditional records. Antimicrobial and anti-inflammatory properties support the rationale. In vitro antiviral activity against respiratory viruses and immunostimulatory properties have been demonstrated.
Plantago major leaves are documented in traditional medicine worldwide for skin diseases including eczema and dermatitis. Anti-inflammatory and antiallergic compounds (plantamajoside, aucubin) that inhibit histamine and prostaglandin synthesis provide a mechanistic basis. Traditional use involves topical application of crushed leaves or leaf extracts to inflamed skin.
Fever reduction is documented as a traditional use of Plantago major in multiple global ethnobotanical records. Antipyretic properties are cited in traditional Persian medicine. P. major extracts contain antipyretic compounds including aucubin and phenolic acids. No dedicated human RCT for antipyretic effect with P. major has been conducted.
Plantago major has documented traditional use for gastritis, stomach inflammation, and peptic complaints across multiple global traditions. Its mucilage content is proposed to coat and protect the gastric mucosa. Pectic polysaccharides from P. major have shown antiulcerogenic activity in rat models, supporting the gastroprotective rationale.
Gout and uric acid-related conditions are documented traditional applications for Plantago in multiple European and Asian folk medicine systems. The diuretic effect of P. major supports urate excretion. Anti-inflammatory mechanisms are relevant to gout flares. No human clinical data for gout specifically with Plantago has been published.
Plantago species are used in traditional medicine for kidney-related complaints. Kidney stones are listed among traditional applications. Psyllium fiber from P. ovata seeds demonstrated reduced renal tubular injury in CKD animal models by modulating the gut–kidney axis and reducing uremic toxin accumulation. Evidence is preclinical and traditional for P. major specifically.
Kidney stones are documented among the traditional indications for Plantago major in global ethnobotanical records. Traditional Chinese Medicine uses the closely related Plantago asiatica seeds specifically for urinary calculi. Diuretic properties documented in preclinical studies may support urinary mineral clearance. No clinical trials for kidney stones with P. major exist.
Plantain has been traditionally used for lung-related ailments including asthma, emphysema, and bronchitis in multiple global traditions. Preclinical studies show anti-inflammatory effects in lung tissue. Traditional Chinese Medicine uses related Plantago asiatica for lung-moistening. Commission E recognizes P. lanceolata for respiratory catarrhs.
Plantain (Plantago major/lanceolata) has been used for centuries in European and Native American herbalism as a poultice for poison ivy rashes, insect bites, and skin inflammations. It contains allantoin, aucubin, and caffeic acid, which provide anti-inflammatory, antimicrobial, and wound-healing activity. EBSCO Health Research Starters notes that evidence indicates topical plantain is helpful for skin conditions including poison ivy.
Plantain is traditionally applied to skin rashes, hives, insect bites, and urticaria across European, American, and Asian folk medicine. Anti-histaminic activity (inhibition of histamine release from mast cells) provides a pharmacological basis for hive relief. Traditional application of fresh crushed leaves directly to skin reactions is one of the most widely recorded uses globally.
Hay fever is among the documented traditional applications of Plantago major in ethnobotanical records. Anti-allergic activity for plantamajoside has been demonstrated in vitro (inhibition of histamine release from mast cells). Traditional use for hay fever and rhinitis is recorded in European and Asian folk medicine. No human allergy RCT exists.
Plantain has a long tradition of use in European and Asian herbal medicine for seasonal respiratory complaints including catarrh, excess mucus, and cold-related cough. Its documented demulcent, expectorant, and mild antimicrobial properties support this use. No dedicated RCTs exist specifically for seasonal respiratory health as a distinct indication.
Plantago is used traditionally for sinus and nasal complaints. Its anti-inflammatory and antimicrobial properties are relevant to sinusitis. Traditional use for hoarseness, rhinitis, and nasal congestion is documented in European and Asian folk medicine. Mucilage may soothe inflamed nasal mucosa. No dedicated human clinical trial for sinusitis with plantain has been published.
Plantago major has a long tradition of use as a diuretic and for urinary tract complaints including cystitis across European, Asian, and Vietnamese traditional medicine. Preclinical diuretic effects have been studied. Traditional Chinese and Vietnamese medicine use Plantago species specifically for urinary tract inflammation.
Traditional medicine systems across Europe, Asia, and Vietnam use Plantago major for urinary tract infections and cystitis. Antimicrobial activity against common uropathogens (E. coli, Klebsiella, Proteus) has been demonstrated in vitro. Diuretic effects documented in animal models may support urinary flushing. No human RCT for UTI with P. major exists.